Seeking Alpha

Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference

BOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc (COCP). (Nasdaq: COCP) announces that its first-in-class pan-viral protease inhibitor CDI-988 has been selected for an oral ...
Seeking Alpha

Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference

BOTHELL, Wash., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc (COCP). (Nasdaq: COCP) announces that President and co-CEO Sam Lee, PhD discussed the scientific foundation and clinical ...
Fix It Homestead on MSN

How to clean after norovirus without overdoing harsh chemicals in a family home

Norovirus turns a cozy family home into a high‑stakes cleanup zone in a matter of hours, and the instinct to drench every ...
AOL

What Actually Kills Norovirus, According to Experts (You Might Already Have It at Home!)

According to many doctors and health professionals, cases of norovirus are on the rise — especially as many return to work and school after a busy holiday season. Commonly known as the “stomach flu” ...
Fix It Homestead on MSN

Norovirus outbreaks are being tracked this season, and your cleaning routine matters more than you think

Norovirus is not a niche winter nuisance. It is one of the most contagious infections you are likely to encounter, and this ...
NBC Connecticut

Norovirus cases driven by ultra-contagious variant are surging. And hand sanitizer won't kill it

Norovirus, the infamous "winter vomiting disease," is surging again across the United States. Norovirus is a highly contagious stomach bug that causes sudden, often violent bouts of diarrhea and ...
Morningstar

Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference | Morningstar

“This year’s Calicivirus Conference will bring together the world's leading norovirus experts, making it the ideal venue to share our pan-viral protease inhibitor CDI-988 Phase 1 data and clinical ...